We are live on
!
Find out more
FMC
First Merchants Corp Portfolio holdings
AUM
$2.84B
1-Year Est. Return
15.58%
This Fund
S&P 500
This Quarter
Est. Return
+10.71%
1 Year Est. Return
+15.58%
3 Year Est. Return
+49.94%
5 Year Est. Return
+66.76%
10 Year Est. Return
+234.29%
AUM
$1.22B
AUM Growth
+$98.3M
(+8.8%)
Cap. Flow
-$12.1M
Cap. Flow
% of AUM
-0.99%
Top 10 Holdings %
Top 10 Hldgs %
26.58%
Holding
214
New
10
Increased
73
Reduced
103
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$3.76M |
| 2 |
Amazon
AMZN
|
+$1.17M |
| 3 |
Ametek
AME
|
+$1.14M |
| 4 |
McDonald's
MCD
|
+$1.07M |
| 5 |
Walmart Inc
WMT
|
+$1.02M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$3.71M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$3.21M |
| 3 |
PepsiCo
PEP
|
+$2.93M |
| 4 |
T. Rowe Price
TROW
|
+$2.62M |
| 5 |
Emerson Electric
EMR
|
+$2.22M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.52% |
| 2 | Healthcare | 10.19% |
| 3 | Financials | 8.01% |
| 4 | Consumer Discretionary | 6.19% |
| 5 | Industrials | 5.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
iShares US Industrials ETF
IYJ
$1.97B
| $240K | 0.02% |
2,098
| – | – |
|
202
General Mills
GIS
$20.1B
| $219K | 0.02% |
3,370
| – | – |
|
203
Bristol-Myers Squibb
BMY
$125B
| $212K | 0.02% |
4,140
| – | – |
|
204
DuPont de Nemours
DD
$18.4B
| $211K | 0.02% |
2,184
-231
| -10% | -$21K |
|
205
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.8B
| $210K | 0.02% |
2,709
| – | – |
|
206
iShares Russell Mid-Cap Value ETF
IWS
$15.6B
| $206K | 0.02% |
+1,770
| New | +$189K |
|
207
Vanguard FTSE Developed Markets ETF
VEA
$226B
| $205K | 0.02% |
+4,270
| New | +$191K |
|
208
iShares S&P 100 ETF
OEF
$20.2B
| $204K | 0.02% |
+915
| New | +$192K |
|
209
Nuveen AMT-Free Municipal Credit Income Fund
NVG
$2.73B
| $152K | 0.01% |
12,880
| – | – |
|
210
Northwest Bancshares
NWBI
$2.27B
| $126K | 0.01% |
+10,080
| New | +$112K |
|
211
Outlook Therapeutics
OTLK
$224M
| $58.2K | ﹤0.01% |
7,459
| – | – |
|
212
Northern Trust
NTRS
$34.3B
| – | – |
-11,401
| Closed | -$792K |
|
213
Truist Financial
TFC
$63.3B
| – | – |
-7,592
| Closed | -$217K |
|
214
VF Corp
VFC
$6.58B
| – | – |
-11,849
| Closed | -$209K |
|
Similar funds
AIP
ADEF
SAI
SL
FISPB
MWM
MSDF
WG
First Merchants Corp's Q4 2023 Portfolio in Review
As of Q4 2023, First Merchants Corp held 214 positions worth $1.22B, up 8.8% from $1.12B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
First Merchants Corp's Q4 2023 filing shows 10 new, 73 increased, 103 reduced and 3 closed positions. Its largest new stake was AstraZeneca: 28,895 shares worth $3.89M. The largest sale was Pfizer, an estimated $3.71M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.
- First Merchants Corp's largest Q4 2023 buy was AstraZeneca: 28,895 shares worth $3.89M.
- First Merchants Corp added most to Amazon in Q4 2023, an estimated $1.17M increase.
- First Merchants Corp's biggest Q4 2023 reduction was Pfizer, cutting an estimated $3.71M.
- First Merchants Corp fully exited Northern Trust in Q4 2023, selling an estimated $792K.
- First Merchants Corp's ten largest holdings make up 27% of its $1.22B portfolio in Q4 2023.
- First Merchants Corp opened 10 new positions and closed 3 in Q4 2023.
- First Merchants Corp's portfolio value rose 8.8% quarter-over-quarter to $1.22B.
Based on First Merchants Corp's 13F filing for Q4 2023, filed 25 Jan 2024.